[Withdrawal phenomena after chronic beta-blockade. Causes and therapeutic consequences].
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects*; D001145:Arrhythmias, Cardiac / Q000139:chemically induced; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D003327:Coronary Disease / Q000139:chemically induced / Q000188:drug therapy; D003645:Death, Sudden / Q000209:etiology; D006331:Heart Diseases / Q000139:chemically induced*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D010096:Oxprenolol / Q000009:adverse effects; D011433:Propranolol / Q000009:adverse effects; D011943:Receptors, Adrenergic, beta / Q000502:physiology; D013375:Substance Withdrawal Syndrome
D000319:Adrenergic beta-Antagonists; D002121:Calcium Channel Blockers; D011943:Receptors, Adrenergic, beta; D010096:Oxprenolol; D011433:Propranolol
Absetzphänomene nach chronischer beta-Blockade. Ursachen und Therapeutische Konsequenzen.